My concern (alluded to yesterday) was that Baker Bros/Acadia might be taking advantage of current circumstances (NEU share price being battered by the Coronavirus market rout and the Acadia decision to pause the Phase 3 trofinetide in Rett trial) to grab a blocking stake in the company and perhaps a Board presence.
Firstly, from an ethical perspective, it wouldn’t sit well with me if Acadia made such a move directly after pausing the trofinetide trial but none of its own trials of pimavanserin.
In addition, I would have concerns that, for an investment of just US$8.5m, Baker Bros/Acadia could in future (improved) times, control Neuren’s deal options.
In short, I’m relieved that there is no evidence that our trofinetide partner is engaging in what I would view as predatory behaviour.
- Forums
- ASX - By Stock
- NEU
- Ann: International institution acquires 14% of Neuren
Ann: International institution acquires 14% of Neuren, page-21
-
- There are more pages in this discussion • 66 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$14.35 |
Change
-0.120(0.83%) |
Mkt cap ! $1.841B |
Open | High | Low | Value | Volume |
$14.47 | $14.53 | $14.26 | $755.5K | 52.35K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 317 | $14.34 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.36 | 264 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 327 | 14.370 |
4 | 291 | 14.360 |
6 | 533 | 14.350 |
4 | 470 | 14.340 |
4 | 534 | 14.330 |
Price($) | Vol. | No. |
---|---|---|
14.410 | 639 | 10 |
14.420 | 446 | 8 |
14.430 | 456 | 6 |
14.440 | 398 | 6 |
14.450 | 461 | 4 |
Last trade - 10.50am 03/09/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |